Evidence Hub

Adjunctive corticosteroids in non-HIV immunocompromised patients with Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis

Gustavo Rosales-Chavez, P. Martínez-Ayala, M. A. Ambriz-Alarcón, B. R. Rubio-Mora, J. C. De Arcos-Jiménez, A. M. López-Yáñez, Alejandro Marín-Castañeda-Barón, Andrés Alejandro Briseño-Hernández et al.

Therapeutic Advances in Infectious Disease, 2026

5,300 participants

Abstract

Background: Pneumocystis jirovecii pneumonia (PJP) in non-HIV immunocompromised adults carries 30%–60% mortality. Adjunctive corticosteroids are standard in HIV-PJP but remain contested in non-HIV PJP. Objectives: To determine whether adjunctive corticosteroids reduce mortality and invasive mechanical ventilation (IMV) in non-HIV PJP, and whether effect estimates differ between randomized and observational study designs. Design: Systematic review and meta-analysis. Data sources and methods: Six databases and two trial registers were searched from inception to February 7, 2026. Randomized and observational studies comparing adjunctive corticosteroids versus no corticosteroids or placebo in non-HIV adults with PJP were eligible. Random-effects meta-analyses (restricted maximum likelihood) of two co-primary outcomes included subgroup, sensitivity, E-value, and Grading of Recommendations Assessment analyses. Results: Twenty-eight studies were included (one randomized controlled trial (RCT), 27 observational; ∼ 5300 patients): 22 contributed corticosteroid-versus-no-corticosteroid comparisons and six contributed dose-comparison data only. Evidence was discordant by design (interaction p=0.006 ): the RCT showed lower IMV (hazard ratio (HR) 0.36, 95% CI 0.14–0.90) and lower 90-day mortality (HR 0.59, 0.37–0.93); regression-adjusted observational studies suggested harm (odds ratio (OR) 1.56, 1.10–2.22); propensity-based estimates were null-compatible. Pre-specified mortality pools…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 5,300 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free